The prevalence of plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children’s hospitals in China

[1]  T. Tan,et al.  Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis , 2007, Journal of Clinical Pathology.

[2]  Jian-Hua Liu,et al.  Detection and characterisation of CTX-M and CMY-2 beta-lactamases among Escherichia coli isolates from farm animals in Guangdong Province of China. , 2007, International journal of antimicrobial agents.

[3]  Wonkeun Song,et al.  Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis. , 2007, Diagnostic microbiology and infectious disease.

[4]  E. S. Moland,et al.  Klebsiella pneumoniae isolate producing at least eight different beta-lactamases, including AmpC and KPC beta-lactamases. , 2007, Antimicrobial agents and chemotherapy.

[5]  E. S. Moland,et al.  Klebsiella pneumoniae Isolate Producing at Least Eight Different β-Lactamases, Including AmpC and KPC β-Lactamases , 2006, Antimicrobial Agents and Chemotherapy.

[6]  Min-Jeong Park,et al.  Increasing trend in the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004. , 2006, Diagnostic microbiology and infectious disease.

[7]  David L Paterson.  Resistance in gram-negative bacteria: enterobacteriaceae. , 2006, The American journal of medicine.

[8]  G. Arlet,et al.  Emergence of DHA-1-Producing Klebsiella spp. in the Parisian Region: Genetic Organization of the ampC and ampR Genes Originating from Morganella morganii , 2006, Antimicrobial Agents and Chemotherapy.

[9]  L. Peterson.  Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance , 2005, Clinical Microbiology and Infection.

[10]  Yunsong Yu,et al.  Nosocomial spread of multi-resistant Klebsiella pneumoniae containing a plasmid encoding multiple beta-lactamases. , 2005, Journal of medical microbiology.

[11]  Y. Arakawa,et al.  Practical Methods Using Boronic Acid Compounds for Identification of Class C β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli , 2005, Journal of Clinical Microbiology.

[12]  S. Schweighart,et al.  Antibakterielle Aktivität und β-Laktamase-Stabilität von elf Oralcephalosporinen , 1990, Infection.

[13]  Y. Chong,et al.  Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins , 1989, Infection.

[14]  J. Pitout,et al.  Phenotypic and Molecular Detection of CTX-M-β-Lactamases Produced by Escherichia coli and Klebsiella spp , 2004, Journal of Clinical Microbiology.

[15]  J. Wu,et al.  Complexity of Klebsiella pneumoniae Isolates Resistant to Both Cephamycins and Extended-Spectrum Cephalosporins at a Teaching Hospital in Taiwan , 2004, Journal of Clinical Microbiology.

[16]  B. Abdalhamid,et al.  Characterization of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom. , 2004, Microbial drug resistance.

[17]  D. Paterson.  "Collateral damage" from cephalosporin or quinolone antibiotic therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  G. Jacoby,et al.  Epidemiology of Conjugative Plasmid-Mediated AmpC β-Lactamases in the United States , 2004, Antimicrobial Agents and Chemotherapy.

[19]  N. Hanson.  AmpC β-lactamases: what do we need to know for the future? , 2003 .

[20]  N. Hanson.  AmpC beta-lactamases: what do we need to know for the future? , 2003, The Journal of antimicrobial chemotherapy.

[21]  E. S. Moland,et al.  Occurrence of Newer β-Lactamases in Klebsiella pneumoniae Isolates from 24 U.S. Hospitals , 2002, Antimicrobial Agents and Chemotherapy.

[22]  M. Inoue,et al.  Investigation of extended-spectrum beta-lactamase in Klebsiellae pneumoniae and Escherichia coli from China. , 2002, Diagnostic microbiology and infectious disease.

[23]  N. Hanson,et al.  Detection of Plasmid-Mediated AmpC β-Lactamase Genes in Clinical Isolates by Using Multiplex PCR , 2002, Journal of Clinical Microbiology.

[24]  George A. Jacoby,et al.  Plasmid-Determined AmpC-Type β-Lactamases , 2002, Antimicrobial Agents and Chemotherapy.

[25]  G. Jacoby,et al.  Plasmid-determined AmpC-type beta-lactamases. , 2002, Antimicrobial agents and chemotherapy.

[26]  E. S. Moland,et al.  Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. , 2002, Antimicrobial agents and chemotherapy.

[27]  Y. Zhang,et al.  Detection of amp C in Enterobacter cloacae in China. , 2001, International journal of antimicrobial agents.

[28]  P. Nordmann,et al.  Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae. , 2001, The Journal of antimicrobial chemotherapy.

[29]  J. Wu,et al.  Dissemination of CTX-M-3 and CMY-2 β-Lactamases among Clinical Isolates of Escherichia coli in Southern Taiwan , 2000, Journal of Clinical Microbiology.

[30]  R. Penn,et al.  Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpC. , 1999, The Journal of antimicrobial chemotherapy.

[31]  A. Medeiros,et al.  Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia , 1997, Antimicrobial agents and chemotherapy.

[32]  O. Gaillot,et al.  Novel transferable beta-lactam resistance with cephalosporinase characteristics in Salmonella enteritidis. , 1997, The Journal of antimicrobial chemotherapy.

[33]  A. Bauernfeind,et al.  [Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins]. , 1990, Infection.